olutasidenib sold brand name rezlidhia anticancer medication used treat relapsed refractory acute myeloid olutasidenib isocitrate taken common adverse reactions include nausea fatiguemalaise arthralgia constipation leukocytosis dyspnea fever rash mucositis diarrhea olutasidenib approved medical use united states december olutasidenib indicated treatment adults relapsed refractory acute myeloid leukemia susceptible isocitrate mutation detected fdaapproved olutasidenib international nonproprietary pharmacologyrelated article stub help wikipedia expanding httpsenwikipediaorgwikiolutasidenib